Is ZoomInfo profitable?
ZoomInfo is a profitable enterprise, consistently generating positive adjusted operating income and substantial unlevered free cash flow from its go-to-market data and intelligence platform. Despite facing challenging macro conditions, software spending pauses, and lower top-line growth trajectories that forced the company to implement aggressive cost-reduction measures and workforce cuts, its underlying business model remains fundamentally cash-generative. Management continues to prioritize maintaining healthy adjusted operating margins even as it restructures pricing tiers and adapts to changing enterprise demands. This persistent profitability allows the company to self-fund its technological pivots and operational shifts without relying heavily on external debt financing.
Related FAQs
Contract Development and Manufacturing Organizations play an indispensable role in modern pharmaceutical and biotechnology pipelines by providing outsourced drug development, clinical trials supply, and commercial-scale manufacturing.
Pharmaron Co., Ltd.
Pharmaron was officially founded in Beijing, China, in 2003 by a team of life science entrepreneurs including Boliang and Larry Lou.
Pearson plc drives its global lifelong learning mission through strategic priorities and operational values centered on execution, quality, trust, and customer obsession.
Pharmaron originated in Beijing, China, where its primary corporate foundation and extensive research and development laboratories are located.
Pharmaron Beijing Co., Ltd.
Pharmaron Beijing Co., Ltd. is a massive, globally integrated contract research, development, and manufacturing organization providing vital laboratory and clinical services to the pharmaceutical and biotechnology industries.
Pharmaron maintains public stock listings on major Asian financial exchanges, allowing institutional and retail investors to trade its shares publicly.
Pharmaron is widely recognized within the pharmaceutical industry as a reliable, scientifically capable partner supporting complex drug development pipelines.
Pharmaron Beijing Co., Ltd. is a premier global contract research, development, and manufacturing organization serving the life sciences and pharmaceutical industries.
Pharmaron functions as an integrated contract research, development, and manufacturing organization, providing comprehensive laboratory services spanning early discovery through commercial-scale production for life sciences clients.
Omron Corporation generates annual consolidated net sales exceeding ¥800 billion to over ¥850 billion (translating to multi-billion-dollar global equivalents), confirming its prominent market position as a premier automation and electronic equipment ...
When assessing specialized life science contract research organizations like Pharmaron through business intelligence platforms such as ZoomInfo, automated database scrapers often track estimated regional profiles or sub-division metrics, whereas offi...
A Contract Manufacturing Organization (CMO) is a pharmaceutical outsourcing provider that focuses strictly on the physical production, batch manufacturing, and commercial packaging of established drug products.
Contract Development and Manufacturing Organizations (CDMOs) in the pharmaceutical industry are specialized outsourced service providers that handle drug development, clinical trial formulation, and commercial-scale manufacturing for biotechnology an...
Franco-Indian Pharmaceuticals operates as a specialized pharmaceutical manufacturing and marketing enterprise delivering healthcare formulations, therapeutic drugs, and medical products across regional distribution networks.
Pharmaron operates as a prominent global contract research organization, serving hundreds of pharmaceutical and biotechnology partners—including top-tier international healthcare enterprises—across multiple continents.
Pharmaron is a premier, technology-driven contract research, development, and manufacturing organization providing comprehensive, integrated services to the global pharmaceutical, biotechnology, and medical device industries.
Pharmaron operates as a premier contract research and manufacturing organization guided by fundamental values emphasizing quality, data integrity, scientific excellence, and trust.
Rosemont Pharmaceuticals operates as a specialized pharmaceutical enterprise generating robust annual revenues centered on oral liquid formulations, specialty medicines, and prescription treatments tailored for patients with swallowing difficulties.
The global pharmaceutical landscape is dominated by multinational corporations that invest heavily in research and development to produce breakthrough therapeutics, vaccines, and medical devices.